Apr 11, 2016 9:10 am EDT Cerecor Announces $1.0 Million Research & Development Grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health
Mar 23, 2016 9:10 am EDT Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
Feb 2, 2016 9:10 am EST Cerecor Announces Initiation of Phase 2 Clinical Trial With CERC-501 for Smoking Cessation
Feb 1, 2016 9:10 am EST Cerecor Inc. to Present at the BIO CEO & Investor Conference in New York City
Jan 19, 2016 9:10 am EST Cerecor Announces Publication Describing Antidepressant Activity of CERC-301 in Preclinical Model
Dec 21, 2015 9:00 am EST Cerecor Inc. Names Uli Hacksell, Chairman of Cerecor and Former CEO of ACADIA, as President and CEO
